Pfizer Inc.
Edit

Pfizer Inc.

https://www.pfizer.com/
Last activity: 15.09.2025
Active
Categories: CareDevelopmentDrugHealthTechInformationLearnMedtechProductScienceWellness
Pfizer Inc.: Breakthroughs that change patients’ lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us.
Likes
504.23K
Followers
5.58M
Website visits
1.6M /mo.
Mentions
1.57K
Location: United States, New York
Employees: 10001+
Total raised: $31B
Founded date: 1848

Investors 8

Funding Rounds 1

DateSeriesAmountInvestors
15.05.2023-$31B-

Mentions in press and media 1574

DateTitleDescription
15.09.2025Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer IncAustralian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's first in class KAT6 inhibitor PF-07248144 now moving to the next stages of clin...
12.09.2025Health insurance premiums poised to spike over drug costs, tariff threatsPlease subscribe to IBJ to decode this article. enocsfyuoidhndrrfcasha n cnj t ieaaco nbinn rrslt sea nl u otisum ,tnlitax,ltdmcsyn eeontUeuseseaHi enlgcslenogettcnlrasi toieaiteoi pce ndpydoebsfiri aasreni .vdtoreal Aueieaelpbenutr a gSa t...
11.09.2025Enveda: $150 Million Series D Raised To Advance Clinical Trials And Enhance LeadershipEnveda, a clinical-stage biotechnology company focused on developing a new generation of small-molecule drugs sourced from nature, has announced a significant milestone with the close of its $150 million Series D funding round. The round wa...
11.09.2025Holding High the Banner of Opening-up and Leading Trade in Services, Beijing Is Setting a New Benchmark for Opening up the Chinese Services Sector: Through the Lens of CIFTISBEIJING, CHINA – Media OutReach Newswire – 11 September 2025 – On September 10, the 2025 China International Fair for Trade in Services (CIFTIS), themed “Embrace Intelligent Technologies, Empower Trade in Services,” opened as scheduled. Cap...
09.09.2025Top EU official von der Leyen to outline plans for dealing with Europe’s challenges in major speechBy LORNE COOK BRUSSELS (AP) — European Commission President Ursula von der Leyen delivers a major state of the union speech on Wednesday addressing the challenges facing the world’s biggest trading bloc and laying out her vision for tacklin...
07.09.2025Trump backs Kennedy on vaccines despite health, political risksWASHINGTON: President Donald Trump is standing by Robert F Kennedy Jr, the health secretary who is upending the US healthcare system, despite congressional pressure, public health concerns and the political risks of changing vaccine policie...
07.09.2025🔥 Quick Fire with Ayodeji AlaranAyodeji Alaran is the founder and CEO of PBR Life Sciences, a healthtech company working to fix Africa’s healthcare data problem. After years of seeing drug oversupply, expiry, and waste across the continent, he launched PBR to help pharmac...
04.09.2025Enveda Raises $150M in Series D FundingEnveda, a Boulder, CO-based clinical-stage biotech company, raised $150M in Series D funding. The round was led by Premji Invest with participation from new and existing investors Baillie Gifford, Kinnevik, Lingotto Investment Management, P...
04.09.2025RFK Jr. casts doubts on vaccines, clashes with Democrats over Covid shot accessHealth and Human Services Secretary Robert F. Kennedy Jr. doubled down on false claims about vaccines during his Senate testimony, as senators grilled him on his sweeping changes to immunization policy and federal health agencies. Kennedy s...
03.09.2025CNBC’s UK Exchange newsletter: Hooked on rebates?The pharmaceuticals sector is at loggerheads with the U.K. government over the amount of branded medicine bought by the National Health Service. The U.K. spends far less on medicine than many of its peers, but the industry wants that to cha...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In